Author: Pathalys Pharma

Pathalys Pharma Presents Positive Data from Pivotal Phase 3 Studies of Upacicalcet in Featured Oral Presentation at ASN Kidney Week 2026

October 23, 2026
Pathalys Pharma Announces Late-Breaking Abstract from Pivotal Phase 3 Program Selected as Featured Oral Presentation at ASN Kidney Week 2026

October 5, 2026

Pathalys Pharma Presents Positive Data from Pivotal Phase 3 Studies of Upacicalcet in Featured Oral Presentation at ASN Kidney Week 2026